PHARMA MAR SA EUR0.6 POST CONSOLIDATIONPHARMA MAR SA EUR0.6 POST CONSOLIDATIONPHARMA MAR SA EUR0.6 POST CONSOLIDATION

PHARMA MAR SA EUR0.6 POST CONSOLIDATION

No trades
See on Supercharts

Price target

49.120.00 0.00%
The 5 analysts offering 1 year price forecasts for 0RC6 have a max estimate of — and a min estimate of —.

Analyst rating

Based on 5 analysts giving stock ratings to 0RC6 in the past 3 months.

EPS

‪0.00‬
Reported
Estimate
Reported
Estimate
Surprise

Revenue

‪0.00‬
Reported
Estimate
Reported
Estimate
Surprise
Be warned

Frequently Asked Questions

0RC6 EPS for the last quarter is 0.12 EUR despite the estimation of −0.07 EUR. In the next quarter EPS is expected to reach 0.02 EUR. Track more of PHARMA MAR SA EUR0.6 POST CONSOLIDATION financials and stay on top of what is up with the company.
In the next quarter PHARMA MAR SA EUR0.6 POST CONSOLIDATION revenue is expected to reach ‪44.60 M‬ EUR. Check out PHARMA MAR SA EUR0.6 POST CONSOLIDATION revenue and earnings and make informed decisions.
According to analysts, 0RC6 price target is 49.12 EUR with a max estimate of 70.00 EUR and a min estimate of 29.60 EUR. Check if this forecast comes true in a year, meanwhile watch PHARMA MAR SA EUR0.6 POST CONSOLIDATION stock price chart and keep track of the current situation with 0RC6 news and stock market news.
We've gathered opinions of 5 analysts rating 0RC6 stock in the past 3 months. Most of them backed up the strong buy trend, and after taking into account other opinions, the overall rating was calculated as buy. Note that it's not a trading advice — your own analysis is still required.